Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)

National Institutes of Health · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

July 12, 2027
Response Due
Active
Status

Opportunity Overview

The National Institutes of Health (NIH) hereby notifies recipient organizations holding specific types of NIH grants, listed within the Activity Code section above, that applications for change of recipient organization may be submitted to this NOFO. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

This is one of 7 active United States Clinical Trials opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNational Institutes of Health
CountryUnited States
CategoryClinical Trials
NAICS93.213, 93.393, 93.8
PublishedJuly 11, 2024
Procurement stageRequest for Proposal (RFP)
Response dueJuly 12, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 11, 2026

Source: U.S. Government (Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Alcohol Health Services Research (R34 Clinical Trial Optional)
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

See every United States Clinical Trials opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Clinical Trials intelligence report in your inbox

A personalized report on United States Clinical Trials opportunities, emailed in 5-10 minutes. One per month, no account needed.